| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 08/03/2006 | US20060171937 Method of treating chronic cardiac disease |
| 08/03/2006 | US20060171934 Methods and compositions using cellular asialodeterminants and glycoconjugates for targeting cells to tissues and organs |
| 08/03/2006 | US20060171928 Monocyte-origin multipotent cell momc |
| 08/03/2006 | US20060171881 Compounds with high monoamine transporter affinity |
| 08/03/2006 | CA2596237A1 Diamine derivative |
| 08/03/2006 | CA2596144A1 Compounds for treating inflammatory and demyelinating diseases |
| 08/03/2006 | CA2595986A1 7-{4-[2-(2,6-dichlor0-4-methylphenoxy)-ethoxy]phenyl}-3,9-diazabicyclo[3.3.1]non-6-ene-6-carboxylic acid cyclopropyl-(2,3-dimethylbenzyl)amides as inhibitors of renin for the treatment of hypertension |
| 08/03/2006 | CA2595942A1 Treatment of degenerative diseases with the x-linked inhibitor of apoptosis |
| 08/03/2006 | CA2594693A1 Medicaments for the prevention or treatment of heart failure comprising administration of an anticholinergic |
| 08/03/2006 | CA2590338A1 Compositions and methods for treating cardiac conditions |
| 08/02/2006 | EP1686130A1 Pyrrolo[2,3-d]pyrimidine compounds as immunosuppressive agents |
| 08/02/2006 | EP1686127A1 New heterocyclylmethyl-substituted pyrazole derivatives and their use for treating cardiovascular diseases |
| 08/02/2006 | EP1686120A2 Methods and compositions utilizing quinazolinones |
| 08/02/2006 | EP1686119A1 Pyrimidine-4-one derivatives as ldl-pla2 inhibitors |
| 08/02/2006 | EP1685841A1 Prevention and treatment of thromboembolic disorders |
| 08/02/2006 | EP1685840A2 Use of tetrahydrofolates for modulating the homocysteine level |
| 08/02/2006 | EP1685837A1 Percutaneous absorption type cerebral protective agent |
| 08/02/2006 | EP1685833A1 Remedy for diabetes |
| 08/02/2006 | EP1685832A1 Nerve regeneration promoters |
| 08/02/2006 | EP1685108A1 1,4-dihydropyridine compounds, pharmaceutical compositions, and methods for the treatment of cardiovascular disease |
| 08/02/2006 | EP1685107A1 1,4-dihydropyridine compounds, pharmaceutical compositions, and methods for the treatment of cardiovascular disease |
| 08/02/2006 | EP1685096A1 Pentafluorosulfanyl benzoylguanidines, method for their production, their use as medicaments or diagnostic agents and medicament containing the same |
| 08/02/2006 | EP1684803A2 Immune modulator comprising whole cell rhodococcus, gordonia, nocardia, dietzia, tsukamurella or nocrdioides bacteria |
| 08/02/2006 | EP1684779A1 Method for controlling angiogenesis in animals |
| 08/02/2006 | EP1684777A2 Effect of beta-glucan on stem cell recruitment and tissue repair |
| 08/02/2006 | EP1684737A1 Pharmaceutical composition containing guaiacol derivatives and syringol derivatives extracted from natural plant vinegar |
| 08/02/2006 | EP1684718A1 Methods of preparing a foam comprising a sclerosing agent |
| 08/02/2006 | EP1605947B1 Use of pteridine derivatives for the treatment of increased intracranial pressure |
| 08/02/2006 | EP1532147B1 Spirosubstituted piperidines as selective melanin concentrating hormone receptor antagonists for the treatment of obesity |
| 08/02/2006 | EP1505965B1 Use of the metabolite of valsartan to inhibit platelet aggregation |
| 08/02/2006 | EP1372737B1 Preparation for the prophylaxis of restenosis |
| 08/02/2006 | EP1333887B1 Combination therapy comprising anti-diabetic and anticonvulsant agents |
| 08/02/2006 | EP1274692B1 Quinazoline compounds |
| 08/02/2006 | EP1267828B1 Pharmaceutical preparations containing saccharose fatty acid esters for controlling the release of active ingredients |
| 08/02/2006 | EP1212328B1 Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage |
| 08/02/2006 | EP1210341B1 Compositions and therapeutic methods involving isoflavones and analogues thereof |
| 08/02/2006 | EP1133476B1 Iminoguanidine derivatives, preparation method, use as medicines |
| 08/02/2006 | EP1014966B1 Pharmaceutical for treatment of neurological and neuropsychiatric disorders |
| 08/02/2006 | EP1006793B1 Anti-arrhythmic composition and methods of treatment |
| 08/02/2006 | CN2801158Y Wetting agent type medicinal plaster for preventing disease |
| 08/02/2006 | CN1812981A Heteroaryloxy nitrogenous saturated heterocyclic derivative |
| 08/02/2006 | CN1812980A Derivatives of piperidinyl- and piperazinyl-alkyl carbamates, preparation methods thereof and application of same in therapeutics |
| 08/02/2006 | CN1812973A Indazole compounds useful as protein kinase inhibitors |
| 08/02/2006 | CN1812812A Serum cholesterol lowering agnet or preventive or therapeutic agent for atherosclerosis |
| 08/02/2006 | CN1812801A Composition for lowering serum uric acid level |
| 08/02/2006 | CN1812776A Inhibition of protein kinase c-mu (pkd) as a treatment for cardiac hypertrophy and heart failure |
| 08/02/2006 | CN1812729A Combinations of vasoprotective agents and formulations containing them |
| 08/02/2006 | CN1810958A Inhibition of nuclear transcription factor NF- kappa B by caffeic acid phenethyl ester (CAPE), derivatives of CAPE, capsaicin (8-methyl-n-vanillyl-6-nonenamide) and resiniferatoxin |
| 08/02/2006 | CN1810842A Longleaf Grateloupia acuminata polysaccharide extract and its prepn and use |
| 08/02/2006 | CN1810836A Human proinsulin-KGD chimeric peptide as new recombinat antithrombotic with thrombocyte GP-IIb-IIIa receptor specificity |
| 08/02/2006 | CN1810828A Fatty acid-carnosine composite and its prepn |
| 08/02/2006 | CN1810281A Externally applied medicine for preventing and treating piles and health briefs therewith |
| 08/02/2006 | CN1810279A Dietotherapeutic Chinese medicine recipe for treating anorectal diseases |
| 08/02/2006 | CN1810277A Chinese medicine composition for treating heart failure and its prepn process |
| 08/02/2006 | CN1810271A Chinese medicine composition for treating apoplexy and its prepn process and use |
| 08/02/2006 | CN1810270A Prepn process of total salvianolic acid |
| 08/02/2006 | CN1810269A Freeze dried perhexiline powder for injection and its prepn process |
| 08/02/2006 | CN1810268A Apoplexy treating medicine composition |
| 08/02/2006 | CN1810262A Chest-relaxing freeze dried powder for injection and its prepn |
| 08/02/2006 | CN1810251A Medicine of treating cerebral ischemia reperfusion injury and its prepn |
| 08/02/2006 | CN1810243A Hypotensor composition |
| 08/02/2006 | CN1810242A Slow-released vincamine capsule and its prepn process |
| 08/02/2006 | CN1810238A Oral arginine prepn for preventing and treating cachexia syndrome |
| 08/02/2006 | CN1810236A Liposome preparation of garlicin |
| 08/02/2006 | CN1267727C Ginkgo leaf composition, and preparing method and use thereof |
| 08/02/2006 | CN1267555C Sea anemone neurotoxin gene Sr4 and application thereof |
| 08/02/2006 | CN1267554C Sea anemone neurotoxin gene Sr5 and application thereof |
| 08/02/2006 | CN1267550C Vascular endothelial growth factor 2 |
| 08/02/2006 | CN1267451C Somatostatin analogues |
| 08/02/2006 | CN1267438C antidepressant indoletetrahydropyridine derivatives of 2,3-dihydro-7h-[1,4] dioxino [2,3-3] indole |
| 08/02/2006 | CN1267435C New process for prepn. of oxabispidines |
| 08/02/2006 | CN1267432C 2-pyridinyl-6,7,8,9-tetrahydropyrimido(1,2-a)pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo(1,2-a)pyrimidin-5(1h)one derivatives |
| 08/02/2006 | CN1267430C Triazole compounds with dopamine -D3-receptor affinity |
| 08/02/2006 | CN1267423C Substituted 2-phenylaminomidazoline phenyl ketone derivatives as IP antagonists |
| 08/02/2006 | CN1267420C 药用活性哌啶衍生物 Pharmaceutically active piperidine derivatives |
| 08/02/2006 | CN1267418C Diarylselenide compounds and their use in human or veterinary medicine and in cosmetics |
| 08/02/2006 | CN1267407C Prodrugs of excitatory amino acids |
| 08/02/2006 | CN1267394C Vitamin D analogues |
| 08/02/2006 | CN1267212C Use of ammonia oxidizing bacteria in medicament,preparation making by same and articles treated with same |
| 08/02/2006 | CN1267126C Chinese medicine for treating coronary heart disease and angina pectoris and its preparation |
| 08/02/2006 | CN1267111C Compound red sage drip pill for treating cardiac and cerebral vascular diseases and its prepn process |
| 08/02/2006 | CN1267107C Extraction method of scorpion active protein liquid |
| 08/02/2006 | CN1267099C Medicament with protective effect against oxidative-toxic substances, particularly against cardiotoxin substances |
| 08/02/2006 | CN1267096C Ginkgo leaf extract injection and its preparation method |
| 08/02/2006 | CN1267094C Orally disintegrating tablet of safflor yellow and its preparation process |
| 08/02/2006 | CN1267090C Garlicin injection emulsion and its preparing method |
| 08/02/2006 | CN1267085C Modifying the fatty acid composition of cell membranes of organs and tissues |
| 08/01/2006 | USRE39219 Isolated Dna |
| 08/01/2006 | US7084243 Glucagon-like peptide-1 analogs |
| 08/01/2006 | US7084240 Crystallization of IGF-1 |
| 08/01/2006 | US7084177 Antidiabetic agents |
| 08/01/2006 | US7084167 A secondary aminemethyl-indole derivatives, for treating diseases or physiological disorders; calcimimetic activity |
| 08/01/2006 | US7084164 Triazole derivative |
| 08/01/2006 | US7084161 Method for treating inflammatory diseases or conditions |
| 08/01/2006 | US7084159 Inhibitors of c-Jun N-terminal kinases (JNK) and other protein kinases |
| 08/01/2006 | US7084156 2-Aminoquinoline compounds |
| 08/01/2006 | US7084142 Anticoagulants; 2-[1S-(4-(ethoxycarbonyl)piperazin-1-yl)carbonyl-3-carboxypropyl]aminocarbonyl-4-(2-methylthiazol-4-yl)methoxyquinoline; antithrombotic agents in the treatment and prevention of thrombosis |
| 08/01/2006 | US7084141 Therapeutic treatment of diabetes with a 4-[piperazine-1-yl]-1,2-dihydro-quinolines; treating tumor growth, glomerulonephritis, inflammation, malarial anemia, septic shock, tumor associated angiogenesis, vitreoretinopathy, psoriasis, graft versus host disease, atopic dermatitis |
| 08/01/2006 | US7084139 Cardiovascular disorders; anticoagulants; antitumor, anticancer agents; Alzheimer's disease; Parkinson's disease |
| 08/01/2006 | US7084127 C2,5′-disubstituted and N6, C2,5′-trisubstituted adenosine derivatives and their different uses |